M. Ide

发表

Identification of a selective inhibitor of transforming growth factor β-activated kinase 1 by biosensor-based screening of focused libraries.

K. Morikami, H. Kashiwagi, T. Kamikawa, 2017, Bioorganic & medicinal chemistry letters.

Smooth isoindolinone formation from isopropyl carbamates via Bischler-Napieralski-type cyclization.

M. Nakata, Y. Saikawa, Y. Yoshida, 2014, Organic letters.

Room-Temperature Metallation of 2-Substituted 1,3-Dithiane Derivatives and Subsequent Coupling with 2,3-Disubstituted Oxiranes

M. Nakata, M. Ide, 1999 .

Synthetic Studies on Biscembranoids. Asymmetric Total Synthesis of the 14-Membered Diene Unit of Methyl Sarcophytoate

M. Nakata, Yuka Matsumoto, M. Ide, 1998 .

Practical deracemization of NM-3, a synthetic angiogenesis inhibitor

K. Isshiki, M. Nakata, N. Kanoh, 2003 .

Stereoselective Synthesis of Tri- and Tetrasubstituted α,β-Unsaturated Esters via Copper-catalyzed Coupling of Enol Triflates of β-Ketoesters with Grignard-based Zinc Ate Complexes

M. Nakata, M. Ide, 2001 .

Synthesis of the c15-c27 portion of venturicidins: A formal total synthesis of venturicidin x

Aya Hirayama, M. Nakata, K. Tsunashima, 2001 .

Enantiospecific Synthesis of the 14-Membered Diene Unit of Methyl Sarcophytoate

M. Nakata, Yuka Matsumoto, M. Ide, 1997 .

Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD).

K. Morikami, H. Kashiwagi, M. Irie, 2016, Chemical & pharmaceutical bulletin.

Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD).

K. Morikami, H. Kashiwagi, T. Kamikawa, 2016, Bioorganic & medicinal chemistry.

Practical Synthesis of Four Stereoisomers of 6-(t-Butyldiphenylsiloxy)-3,5-dimethyl-1-(triphenylmethoxy)hexane-2,4-diol via Dithiane Coupling with Oxirane

M. Nakata, K. Tsunashima, M. Ide, 1999 .